In this study we evaluated the expression of IDO-1 in NSCLC, both in tumor cells and in tumor immune infiltrate, the prognostic role of IDO-1 expression in terms of OS in different NSCLC sub-populations and its possible correlations between other immune checkpoints in this setting. This evidence concerns the gene IDO1 and neoplasm.